Take a fresh look at your lifestyle.

PharmaMar opens the week on the Ibex with falls, although it manages to save 100 euros


This was the big week for PharmaMar. The Spanish pharmaceutical company has become part of the Ibex 35, the select group that includes the 35 securities with the most liquidity in the country. But he did it at a bad time. The selective Spanish has fallen in the last five sessions by 4.35% and has dragged PharmaMar in the falls.

The pharmaceutical more than 1.3% has been left in the weekly calculation And that despite the fact that this Friday has led the advances of the selective, it has closed with a rise of 3.5%. It has only been able to close one more day in green, last Wednesday, then it rose 5.11%.

In the two positive days it has registered strong increases but the strong falls have had more weight. On Monday it fell 5%, falls that were only spared in the Ibex Viscofan, which rose 0.8%. To this setback we must add that of last Thursday of 3.75% and that of Tuesday, although this time it was milder, of 0.81%.

To get the positive side out of PharmaMar's first week on the Ibex 35 is that has managed to save the 100 euros, a level that it recovered after the news of its entry in the Spanish index was known.

In normal seasons, a new value is received by the Ibex with rises but this has not been a normal week. If there were rises after its entry was known, it came to advance about 8%.

"The companies" novice "in the selective of reference They also tend to attract the attention of many investors who had not noticed them before, at the same time that they see in the recently incorporated a new “toy” in the operation ", explains Aitor Méndez, an analyst at IG.

But this week's falls should not be given too much importance, which is why it has been an atypical week. In fact, the experts at ForexNews.online are optimistic about its price. "It does not have significant resistance up to the annual highs at 138.60 euros ", explains José María Rodríguez, technical analyst of this medium.

The reason for this trust? "The titles of PharmaMar they are holding up the general selling pressure of the market quite well, since the price has barely changed ", concludes the expert.


Leave A Reply

Your email address will not be published.